Oxydecahydronaphthalene modulators of HM74

Details for Australian Patent Application No. 2005216878 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Minnich, Anne; Eishingdrelo, Haifeng; Kuntzweiler, Theresa; Henke, Stephan; Angelastro, Michael

Agent Watermark

Pub. Number AU-B-2005216878

PCT Pub. Number WO2005/082352

Priority 60/546,012 20.02.04 US

Filing date 10 February 2005

Wipo publication date 9 September 2005

Acceptance publication date 17 June 2010

International Classifications

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

C07D 311/02 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/082352 Priority application(s): WO2005/082352

17 June 2010 Application Accepted

  Published as AU-B-2005216878

14 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216879-Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation

2005216874-Dental model tray and associated articulator